South Korea Biochip Market Size & Outlook, 2025-2030
Related Markets
South Korea biochip market highlights
- The South Korea biochip market generated a revenue of USD 174.2 million in 2024 and is expected to reach USD 410.8 million by 2030.
- The South Korea market is expected to grow at a CAGR of 14.7% from 2025 to 2030.
- In terms of segment, dna chips was the largest revenue generating type in 2024.
- Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.
Biochip market data book summary
| Market revenue in 2024 | USD 174.2 million |
| Market revenue in 2030 | USD 410.8 million |
| Growth rate | 14.7% (CAGR from 2025 to 2030) |
| Largest segment | Dna chips |
| Fastest growing segment | Lab-on-chip |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | DNA Chips, Protein Chips, Lab-on-chip, Tissue Arrays, Cell Arrays |
| Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.3% of the global biochip market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan biochip market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 790.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biochip Market Scope
Biochip Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Randox | View profile | 1001-5000 | Crumlin, Antrim, United Kingdom, Europe | http://www.randox.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Standard BioTools Inc | View profile | 539 | 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 | https://www.standardbio.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
South Korea biochip market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 44.6% in 2024. Horizon Databook has segmented the South Korea biochip market based on dna chips, protein chips, lab-on-chip, tissue arrays, cell arrays covering the revenue growth of each sub-segment from 2018 to 2030.
Genomic medicine is a rapidly growing industry in South Korea, with much popularity gained by genetic testing, genomic research, and precision medicine. In addition, policymakers are increasingly focusing on DTC genetic tests & services, which is anticipated to favor the entry of emerging companies.
Widespread penetration of genetic testing products in South Korea, especially increased demand for personalized care for cancer and other hereditary diseases. However, few developments have been observed in the QA of private laboratories, and lack of effective training of health professionals & favorable health coverage are collectively expected to hamper the market growth to a certain extent.
South Korea exhibits strong potential for R&D capabilities in pharmaceutical and biopharmaceutical sectors, which is expected to boost the demand for genomics products in research. Cancer research has become a national priority for the Korean government.
Reasons to subscribe to South Korea biochip market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea biochip market databook
-
Our clientele includes a mix of biochip market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea biochip market, including forecasts for subscribers. This country databook contains high-level insights into South Korea biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea biochips market size, by type, 2018-2030 (US$M)
South Korea Biochip Market Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
